Brief: Vivos Therapeutics Provides Update On Second Quarter Earnings Delay
22/08/2022 21:46
Aug 22 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS PROVIDES UPDATE ON SECOND QUARTER
EARNINGS
DELAY
* VIVOS THERAPEUTICS INC - NOT BE FILING OUR FORM 10-Q FOR
Q2 AND
RELEASING OUR RESULTS OF OPERATIONS TODAY AS WE HAD ANTICIPATED
* VIVOS THERAPEUTICS INC - WE BELIEVE WE HAVE POSITIONED
VIVOS TO
POTENTIALLY ACHIEVE POSITIVE CASH FLOW IN EARLY 2024
* VIVOS THERAPEUTICS INC - DELAY DUE TO A REQUIRED TECHNICAL
REEVALUATION OF OUR REVENUE RECOGNITION POLICY
Source text for Eikon: ID:nGNX45DKQH
Further company coverage: VVOS.O
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth